Medtronic has announced the U.S. launch of Adaptix Interbody System, a navigated titanium implant with Titan nanoLOCK surface technology, a blend of surface textures on the macro, micro, and nano levels.
Hand-out Medtronic plc
Medtronic Adaptix
Adaptix™ Interbody System with Titan nanoLOCK™ Surface Technology
The Adaptix Interbody System, mirrored after the veteran Capstone Spinal System, touts improved features for increased strength, subsidence resistance easy insertion, and data-backed bone growth. The announcement was made during the virtual edition of the North American Spine Society (NASS) annual meeting. Adaptix received Food and Drug Administration (FDA) approval in August 2020.
This milestone represents the first 3D printed titanium implant, developed in house by Medtronic engineers, that incorporates the Titan nanoLOCK Surface Technology.
Titan Spine, acquired in 2019, pioneered this surface technology, which demonstrates the elements to be considered a nanotechnology for spinal devices as outlined in the FDA nanotechnology guidance document.
J. Justin Seale, of OrthoArkansas Spine Institute, said: "Adaptix Interbody System allows me the best chance to meet my patients' needs by confidently placing the implant under navigation and trusting the Titan nanoLOCK Surface Technology to allow the implant to promote fusion. Surface technology, material type, and implant design all play a role in bone growth process during fusion. The unique features and world-class technologies make the Adaptix Interbody System a truly differentiated implant."
Sharrolyn Josse, vice president and general manager of Medtronic Core Spine and Biologics division, added: "Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK Surface Technology. It is a fully navigated procedure, leveraging our leadership in navigation."
